
Sign up to save your podcasts
Or
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.
4.4
6262 ratings
Dr Rebecca Dent from National Cancer Centre Singapore and Dr Nancy Lin from Dana-Farber Cancer Institute in Boston, Massachusetts, discuss important efficacy and safety data from 2024 related to the management of localized and advanced breast cancers.
CME information and select publications here.
17 Listeners
32 Listeners
13 Listeners
666 Listeners
12 Listeners
69 Listeners
0 Listeners
113 Listeners
45 Listeners
488 Listeners
56 Listeners
101 Listeners
45 Listeners
60 Listeners
8,563 Listeners
169 Listeners